BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18339697)

  • 1. Immunodetection of glycosylated NT-proBNP circulating in human blood.
    Seferian KR; Tamm NN; Semenov AG; Tolstaya AA; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
    Clin Chem; 2008 May; 54(5):866-73. PubMed ID: 18339697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.
    Seferian KR; Tamm NN; Semenov AG; Mukharyamova KS; Tolstaya AA; Koshkina EV; Kara AN; Krasnoselsky MI; Apple FS; Esakova TV; Filatov VL; Katrukha AG
    Clin Chem; 2007 May; 53(5):866-73. PubMed ID: 17384012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting Edge of Brain Natriuretic Peptide (BNP) Research - The Diversity of BNP Immunoreactivity and Its Clinical Relevance.
    Kuwahara K; Nakagawa Y; Nishikimi T
    Circ J; 2018 Sep; 82(10):2455-2461. PubMed ID: 30135320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating fragments of N-terminal pro-B-type natriuretic peptides in plasma of heart failure patients.
    Foo JY; Wan Y; Schulz BL; Kostner K; Atherton J; Cooper-White J; Dimeski G; Punyadeera C
    Clin Chem; 2013 Oct; 59(10):1523-31. PubMed ID: 23820130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
    Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Susceptibility of B-Type Natriuretic Peptide (BNP) and BNP Precursor (proBNP) to Cleavage by Neprilysin: The N-Terminal Part Does Matter.
    Semenov AG; Katrukha AG
    Clin Chem; 2016 Apr; 62(4):617-22. PubMed ID: 26864319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure.
    Nishikimi T; Ikeda M; Takeda Y; Ishimitsu T; Shibasaki I; Fukuda H; Kinoshita H; Nakagawa Y; Kuwahara K; Nakao K
    Heart; 2012 Jan; 98(2):152-61. PubMed ID: 21719557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site.
    Semenov AG; Postnikov AB; Tamm NN; Seferian KR; Karpova NS; Bloshchitsyna MN; Koshkina EV; Krasnoselsky MI; Serebryanaya DV; Katrukha AG
    Clin Chem; 2009 Mar; 55(3):489-98. PubMed ID: 19168558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of BNP and NT-proBNP Immunoassays in Light of the Diverse and Complex Nature of Circulating BNP-Related Peptides.
    Semenov AG; Feygina EE
    Adv Clin Chem; 2018; 85():1-30. PubMed ID: 29655458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining the use of amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the prognosis of hospitalized heart failure patients.
    Wang Y; Zhang R; Huang Y; Zhai M; Zhou Q; An T; Huang Y; Zhao X; Tian P; Zhang Y; Zhang J
    Clin Chim Acta; 2019 Apr; 491():8-14. PubMed ID: 30594544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides.
    Ala-Kopsala M; Magga J; Peuhkurinen K; Leipälä J; Ruskoaho H; Leppäluoto J; Vuolteenaho O
    Clin Chem; 2004 Sep; 50(9):1576-88. PubMed ID: 15265819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood.
    Tamm NN; Seferian KR; Semenov AG; Mukharyamova KS; Koshkina EV; Krasnoselsky MI; Postnikov AB; Serebryanaya DV; Apple FS; Murakami MM; Katrukha AG
    Clin Chem; 2008 Sep; 54(9):1511-8. PubMed ID: 18606632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amino-terminal pro-brain natriuretic peptide and brain natriuretic peptide measurements under various detection conditions in patients with chronic heart failure].
    Wang WJ; Zhang XM; Wang Q; Wen DM; Ouyang NL; Cui YL; Li F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Aug; 39(8):695-9. PubMed ID: 22169413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship.
    Takase H; Dohi Y
    Eur J Clin Invest; 2014; 44(3):303-8. PubMed ID: 24372567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration.
    Bargnoux AS; Klouche K; Fareh J; Barazer I; Villard-Saussine S; Dupuy AM; Leray-Moragues H; Giuliani I; Canaud B; Cristol JP
    Clin Chem Lab Med; 2008; 46(7):1019-24. PubMed ID: 18624622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposing the High Heterogeneity of Circulating Pro B-Type Natriuretic Peptide Fragments in Healthy Individuals and Heart Failure Patients.
    Amplatz B; Sarg B; Faserl K; Hammerer-Lercher A; Mair J; Lindner HH
    Clin Chem; 2020 Sep; 66(9):1200-1209. PubMed ID: 32797158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.